Related Experiment Video
Updated: May 8, 2026
13:18
Single Oocyte Bisulfite Mutagenesis
Published on: June 27, 2012
A genome-wide DNA methylation study in azoospermia.
F Ferfouri1, F Boitrelle, I Ghout
1Department of Reproductive Biology, Cytogenetics, Gynecology and Obstetrics, Poissy Saint Germain Medical Center, Poissy, France; EA 2493, University of Versailles Saint-Quentin, Versailles, France.
Andrology
|September 3, 2013
Summary
This study reveals distinct DNA methylation patterns in testicular tissue differentiating obstructive azoospermia (OA) from non-obstructive azoospermia (NOA). These epigenetic markers can potentially classify azoospermia types and identify genes involved in idiopathic NOA.
Area of Science:
- Reproductive Biology
- Epigenetics
- Genomics
Background:
- Azoospermia, the absence of sperm in ejaculate, affects male fertility.
- Understanding the molecular basis of different azoospermia types is crucial for diagnosis and treatment.
- Genome-wide DNA methylation differences in testicular tissue between obstructive azoospermia (OA) and non-obstructive azoospermia (NOA) are not well characterized.
Purpose of the Study:
- To assess genome-wide DNA methylation profiles in testicular tissue from azoospermic patients.
- To identify distinct DNA methylation patterns associated with obstructive azoospermia (OA) and non-obstructive azoospermia (NOA).
- To explore potential epigenetic markers for classifying azoospermia and understanding idiopathic NOA mechanisms.
Main Methods:
- Genome-wide DNA methylation analysis using the Illumina Infinium Human Methylation27 BeadChip array.
- Comparison of DNA methylation profiles between 94 azoospermic patients categorized into OA, NOA with successful sperm retrieval (TESE+), and NOA with failed sperm retrieval (TESE-).
- Analysis of relative M-values for CpG sites to identify significant methylation differences.
Main Results:
- Significant differences in DNA methylation profiles were observed between NOA and OA groups, with over 9000 differentially methylated CpG sites.
- A subset of 212 CpG sites showed substantial methylation differences (relative M-value >3), enabling accurate classification of patients into OA or NOA groups.
- In the NOA group, 78 of these 212 CpG sites were hypomethylated and 134 were hypermethylated compared to the OA group.
- Fourteen testis-specific genes were highlighted, and identified genes may offer insights into the mechanisms of idiopathic NOA.
Conclusions:
- Genome-wide DNA methylation patterns in testicular tissue can effectively differentiate between obstructive azoospermia (OA) and non-obstructive azoospermia (NOA).
- A specific set of 212 CpG sites can serve as epigenetic biomarkers for classifying azoospermia subtypes.
- The identified differentially methylated genes provide potential targets for understanding the pathogenesis of idiopathic non-obstructive azoospermia.
